Medical Hair Loss Treatment by Dr. Vicky Jain · Plastic & Reconstructive Surgeon
Losing 50 to 100 hairs per day is normal. Hair follicles cycle through growth, rest, and shedding phases continuously, and this daily shedding is part of that cycle. Hair fall becomes a clinical concern when the rate of shedding exceeds the rate of regrowth, when follicles begin producing thinner and shorter hairs with each cycle, or when bald patches or a receding hairline develop. The distinction between temporary hair fall and progressive hair loss matters because the causes, investigations, and treatments are different.
Temporary hair fall, called telogen effluvium, is triggered by a physiological stress: illness, surgery, nutritional deficiency, significant weight loss, hormonal change, or emotional stress. The follicles enter a resting phase simultaneously rather than in the normal staggered pattern, producing a noticeable increase in shedding 2 to 3 months after the trigger. This type of hair fall is often reversible once the underlying cause is addressed.
Progressive hair loss, the most common form being androgenetic alopecia or pattern baldness, is driven by genetics and the effect of DHT hormone on genetically susceptible follicles. The follicles miniaturize progressively, producing finer hair with shorter growth cycles until they stop producing visible hair entirely. This process is not reversible in the areas where follicles have been permanently lost, but it can be slowed and in early stages partially improved with the right medical management.
Not all hair fall requires medical attention. Shedding within the normal daily range that is not progressing over weeks and has an identifiable temporary trigger can be monitored before seeking treatment. The following signs indicate that assessment is appropriate and that waiting is likely to make the situation harder to treat.
Seek assessment when you notice a hairline that is visibly higher or further back than it was 6 to 12 months ago, thinning at the crown that shows scalp through the hair, consistently more hair than usual on the pillow, shower drain, or brush over several weeks, patchy hair loss in any area of the scalp or beard, or hair that is noticeably finer and shorter than it used to be in the same areas. Earlier assessment produces better treatment outcomes across all causes of hair loss.
The most common cause of hair loss in both men and women. Driven by genetic sensitivity to DHT hormone, which causes follicle miniaturization in a predictable pattern. In men this produces a receding hairline and crown thinning. In women it produces diffuse thinning with widening of the parting. Progressive without treatment.
Diffuse shedding triggered by a physiological stress event 2 to 3 months prior. Common triggers include fever, surgery, significant weight loss, nutritional deficiency, childbirth, and emotional stress. Often reversible once the trigger is addressed, though recovery takes 6 to 12 months.
Iron deficiency is the most common nutritional cause of hair fall, particularly in premenopausal women. Vitamin D deficiency, low B12, and inadequate protein intake also contribute. Correcting the deficiency is the treatment. Hair loss from nutritional causes does not respond to PRP or transplant until the deficiency is addressed.
Thyroid disorders, PCOS, and significant hormonal changes including postpartum hormonal shifts and perimenopause can cause or worsen hair loss. A thyroid function test and hormonal panel are part of the standard investigation for hair loss in women.
An autoimmune condition where the immune system attacks hair follicles, producing patchy hair loss on the scalp, beard, or eyebrows. Ranges from small coin-sized patches to total scalp or body hair loss. Requires specific immunological management distinct from androgenetic alopecia treatment.
Chronic dandruff, seborrheic dermatitis, scalp psoriasis, and fungal infections create a scalp environment that worsens hair loss and can cause direct follicle damage in severe cases. Treating the scalp condition is a prerequisite to any hair loss treatment.
Not all hair fall requires medical attention. Shedding within the normal daily range that is not progressing over weeks and has an identifiable temporary trigger can be monitored before seeking treatment. The following signs indicate that assessment is appropriate and that waiting is likely to make the situation harder to treat.
Seek assessment when you notice a hairline that is visibly higher or further back than it was 6 to 12 months ago, thinning at the crown that shows scalp through the hair, consistently more hair than usual on the pillow, shower drain, or brush over several weeks, patchy hair loss in any area of the scalp or beard, or hair that is noticeably finer and shorter than it used to be in the same areas. Earlier assessment produces better treatment outcomes across all causes of hair loss.
Male pattern baldness follows the Norwood scale, progressing from frontal recession and temple thinning through crown involvement to more extensive loss over years or decades. The genetically resistant donor zone at the back and sides of the scalp is preserved, making most men with androgenetic alopecia good candidates for hair transplant when loss has progressed to a stable pattern.
Female pattern hair loss is more diffuse. Rather than receding in a predictable frontal pattern, women typically experience thinning across the top of the scalp with preserved hairline, widening of the parting, and reduced overall density. The donor zone is less clearly defined and often thinner than in men. Hormonal investigation is more important in women because PCOS, thyroid dysfunction, and postpartum change are common contributing causes that respond to medical management. Women with female pattern hair loss often respond well to PRP and medical therapy with transplant reserved for patients with adequate donor density and localized areas of significant loss.
Hair transplant is appropriate when bald or significantly thinned areas are visible and follicles in those areas are no longer producing visible hair. At this stage, medical management and PRP maintain the remaining native hair but cannot restore growth in the already bald zones. Transplant moves permanent follicles from the donor area to the recipient zone, creating new growth that was not achievable non-surgically. Learn more about{" "} hair transplant .
Transplant timing also requires hair loss to be in a stable phase. Operating during active rapid loss risks transplanting into areas that will lose surrounding native hair in subsequent years, creating an unnatural appearance as the native hair thins around the stable transplant. Dr. Jain assesses loss stability during consultation and may recommend medical management for 6 to 12 months before transplant to confirm stability before proceeding.
Nutritional support for hair health is relevant when the cause of hair loss is deficiency-related and as a supporting measure alongside medical and procedural treatment for other causes. Hair follicles are among the most metabolically active cells in the body. They require adequate protein, iron, zinc, biotin, and vitamins B12 and D to maintain normal growth cycles. Correcting deficiencies identified on blood work is the priority. General supplementation without confirmed deficiency produces minimal benefit.
Dietary sources of protein including eggs, legumes, dairy, and lean meat support hair structure. Iron-rich foods including leafy vegetables, lentils, and lean red meat support oxygen delivery to follicles. Biotin from nuts, seeds, and eggs supports keratin production. Avoiding crash diets, which trigger telogen effluvium, and managing chronic stress through sleep, activity, and stress reduction are the lifestyle factors with the most consistent relationship to hair health maintenance.
Patient Satisfaction
Would Recommend
Years Experience
Justdial Rating
Took time to listen; I left informed and confident. Excellent consultation.
Professional, caring, and clear at every step. Recovery went smoothly. Highly recommended.
Hair fall refers to daily shedding within the normal range of 50 to 100 hairs, or temporary increased shedding from a reversible cause such as stress or nutritional deficiency. Hair loss refers to progressive reduction in hair density due to follicle miniaturization or permanent follicle damage, as seen in androgenetic alopecia. The distinction matters because the treatments are different. Temporary hair fall often resolves by addressing the underlying cause. Progressive hair loss requires ongoing medical management or surgical restoration.
In early androgenetic alopecia where follicles are miniaturizing but still present, medical management and PRP can slow progression and partially improve density. This is not full reversal but meaningful improvement. In established baldness where follicles have permanently stopped producing hair, the only way to restore growth in those areas is hair transplant. The earlier hair loss is treated, the more reversible the outcome.
The standard panel includes complete blood count to assess for anemia, serum ferritin to assess iron stores, thyroid function tests, vitamin D and B12 levels, and in women a hormonal panel including prolactin and androgens when PCOS is suspected. These tests identify correctable medical causes of hair loss that medical management addresses directly before any procedural treatment is considered.
Stress-triggered telogen effluvium causes diffuse shedding that is usually temporary and reversible once the stressor resolves and adequate recovery time passes, typically 6 to 12 months. However, chronic ongoing stress maintained over years can accelerate the progression of underlying androgenetic alopecia in genetically susceptible individuals. Stress-related shedding does not cause permanent follicle loss in the way that androgenetic alopecia does.
Yes. Minoxidil has a well-established long-term safety record with decades of use in both topical and oral forms. The main limitation is that it requires continuous use. Stopping Minoxidil resumes the hair loss process that it was suppressing, often with a noticeable shedding event in the weeks following discontinuation. Patients who start Minoxidil should understand this before beginning treatment.
PRP is more appropriate when follicles are still present in the thinning area and the patient wants to slow progression, improve density, and delay or avoid surgery. PRP is not appropriate as a substitute for transplant in areas where follicles are no longer present. Transplant is more appropriate when bald areas with no functional follicles are the primary concern. Many patients use PRP first to preserve existing hair and proceed to transplant when loss has progressed to an appropriate surgical stage.
Yes. Hair loss associated with PCOS is primarily hormonal and driven by elevated androgen levels. Medical management addressing the hormonal component, alongside Minoxidil and nutritional support, produces meaningful improvement in most PCOS-related hair loss cases. PRP can support improvement in hair density alongside medical management. Transplant is generally not the first-line treatment for PCOS-related hair loss because the hormonal cause continues to affect native hair unless managed medically.
This requires a proper assessment. The right treatment depends on the cause of your hair loss, the degree and pattern of loss, whether follicles are still present in affected areas, your age, and your goals. Dr. Jain assesses all of these factors during consultation and provides a specific recommendation rather than a generic protocol. Patients who have tried treatments without improvement from self-directed care often find that a cause they were not aware of was contributing to their loss.